MRVI Maravai LifeSciences Holdings,
$6.53▼ -2.97%
Healthcare
Other
After hours
$6.53▼ -0.05%
Sep 11, 7:59 PM ET
Volume 2.84M
Avg Volume (10D) 3.27M
Key Metrics & Fundamentals
Market Cap
$2.42B
P/E Ratio
–
Div Yield
–%
52W Range
2.55 - 9.42
% vs 50 MA
-4.43%
% vs 200 MA
42.91%
RSI-14
40.8
MACD Histogram
-0.1800
Beta (1Y vs SPY)
1.27
Free Cash Flow
$3.62M
Gross Rev
$51.44M
Gross Profit
$20.65M
EBITDA
-$608,000
COGS
$30.79M
Operating Exp
$35.77M
Operating Income
-$15.12M
EBIT
-$15.12M
Pretax Income
-$21.80M
Net Income
-$12.42M
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News
UBS Adjusts Maravai Lifesciences Price Target to $8 From $2.50, Maintains Neutral Rating
MT Newswires · Sep 9, 2026 1:37 PM
Sector Update: Healthcare Stocks Fall Late Afternoon
MT Newswires · Aug 20, 2026 7:47 PM
Top Midday Gainers
MT Newswires · Aug 20, 2026 5:40 PM
Maravai (MRVI) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 14, 2026 12:16 AM
Deutsche Bank Adjusts Maravai Lifesciences PT to $8 From $6, Maintains Buy Rating
MT Newswires · Aug 7, 2026 12:58 PM
Maravai LifeSciences Holdings, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 7, 2026 12:30 PM
Maravai LifeSciences Q2 Earnings Call Highlights
MarketBeat · Aug 7, 2026 5:04 AM
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 6, 2026 9:40 PM
Maravai LifeSciences Reports Second Quarter 2026 Financial Results
Business Wire · Aug 6, 2026 8:01 PM
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
Business Wire · Jul 22, 2026 8:02 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See MRVI's money flow as a full page
Social Sentiment
Avg +0.53 · 3 posts
DiscussionTradeKeen to get opinion about my progress so far
r/wallstreetbets · Jun 18, 2025
The author identifies MRVI as a poor performing stock, indicating a negative sentiment.
negative
+0.30
DDPriceTargetMaravai LifeSciences Holdings, Inc. (MRVi) -An Under $5 Gem with Biggest Upside Potential
r/wallstreetbets · Jan 21, 2025
The post’s enthusiastic tone and focus on potential upside indicate positive sentiment toward the stock.
positive
+0.70
DiscussionTrade$mrvi
r/options · Nov 14, 2024
The author expresses a bullish opinion on MRVI, highlighting its CleanCap technology and acknowledging the post-COVID price drop but maintains a positive outlook.
positive
+0.60
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.